Findings showed patients on setmelanotide saw a mean BMI reduction of 16.5% from baseline compared with a 3.3% increase for those on placebo at week 52. Topline data were announced from a phase 3 ...

Patients who underwent NeuroSAFE during nerve-sparing surgery showed improvement in erectile function at 12 months and urinary continence at 3 months. HealthDay News — Use of the NeuroSAFE ...

and Sun Pharmaceutical Industries Ltd. announced that SPARC has licensed out Xelpros (Latanoprost BAK-free eye drops) to a subsidiary of Sun Pharma for the US market. On 1 August 2015, Sun Pharma ...

More importantly, Sun has a solid unfolding pipeline in specialty business which includes Elepsia, Bromsite, MK3222 – Tildrakizumab Infusmart, Xelpros, and Dexasite. This will drive its profitability ...